1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Metastatic Sarcoma: new trials by email Literature Review of Metastatic Sarcoma trials Research Report on Metastatic Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) LV305, G305, LV305-matching placebo - Synovial Sarcoma, Cancer | Phase 3 | Terminated | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 | 2018-09-18 | 2020-04-16 |
Neoplasms (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1)
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)
Canada (1) · United States (1)